IP Library Granted Patent US 7,838,648
Granted Patent B2
US 7,838,648 · App. 12/464,274 · Granted Nov 23, 2010

Purified SR-p70 protein

Assignee: Sanofi Aventis
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,838,648
App. No.
12/464,274
Granted
Nov 23, 2010
Kind
B2
Abstract

The invention relates to new nucleic acid sequences of the family of tumor-suppressing genes related to the gene for the p53 protein, and to corresponding protein sequences.

Claims (7)

1. An isolated nucleic acid sequence coding for a polypeptide comprising amino acid sequence SEQ ID NO:6.

2. An isolated nucleic acid sequence coding for a polypeptide consisting essentially of amino acid sequence SEQ ID NO:6.

3. An isolated nucleic acid sequence coding for a polypeptide comprising the amino acid sequence from residue 111 to residue 309 of SEQ ID NO:6.

4. A cloning or expression vector comprising a nucleic acid sequence according to claim 1 .

5. A vector, according to claim 4 , which is plasmid pSE1.

6. An isolated host cell transfected by a vector according to claim 5 .

7. A transfected host cell, according to claim 6 which is E. coli MC 1061.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2010
From: CAPUT, DANIEL; FERRARA, PASCUAL; KAGHAD, AHMED MOURAD
To: SANOFI
Reel/Frame 025068/0416 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2010
From: SANOFI
To: SANOFI-SYNTHELABO
Reel/Frame 025068/0466 →
CHANGE OF NAME Recorded Sep 30, 2010
From: SANOFI-SYNTHELABO
To: SANOFI-AVENTIS
Reel/Frame 025068/0528 →
Priority Claims (1)
FR 96 01309 · Feb 2, 1996 · national
Continuity (3)
Division 1112263600 · May 5, 2005
Continuation 0912500500
Related Publication 20090258409A1 · Oct 15, 2009